Cite

APA Citation

    Simon, M. A., Hanrott, K., Budd, D. C., Torres, F., Grünig, E., Escribano‐Subias, P., Meseguer, M. L., Halank, M., Opitz, C., Hall, D. A., Hewens, D., Powley, W. M., Siederer, S., Bayliffe, A., Lazaar, A. L., Cahn, A., & Rosenkranz, S. (2022). an open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension. Pulmonary circulation, 12, n/a. http://access.bl.uk/ark:/81055/vdc_100153444205.0x00000e
  
Back to record